Home / Technology / Tata Elxsi Launches AI Platform for Faster Medical Devices
Tata Elxsi Launches AI Platform for Faster Medical Devices
27 May
Summary
- New platform AnaTel uses AI agents for healthcare software development.
- Aims to reduce development timelines from weeks to 72 hours.
- Expected to boost productivity by up to 60% for medtech companies.
Tata Elxsi has introduced AnaTel, an innovative AI-native software development platform specifically for the healthcare and medical technology sectors. This platform was co-developed in collaboration with OpenAna, integrating autonomous AI agents to streamline the software delivery process.
AnaTel's capabilities span the full software lifecycle, from initial requirements and architecture to testing, deployment, verification, and compliance documentation. It is designed to support the preparation of critical regulatory artifacts, including traceability matrices and eSTAR-aligned submissions, crucial for navigating FDA and European medical device guidelines.
The platform promises substantial efficiency gains, with expectations to shorten Software-as-a-Medical-Device (SaMD) development and change assessment cycles from several weeks down to a mere 72 hours. This acceleration is coupled with a projected productivity increase of up to 60%, empowering engineering and regulatory experts.
Sreevatsa Sahasranaman of Tata Elxsi highlighted AnaTel's role in accelerating regulatory-ready software engineering by embedding AI agents within development workflows. Rajiv Sondhi of OpenAna emphasized the platform's mission to provide reliable AI co-engineers for demanding fields like healthcare, where safety and compliance are paramount.
